Your browser doesn't support javascript.
loading
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma.
Escudier, Bernard; Sharma, Padmanee; McDermott, David F; George, Saby; Hammers, Hans J; Srinivas, Sandhya; Tykodi, Scott S; Sosman, Jeffrey A; Procopio, Giuseppe; Plimack, Elizabeth R; Castellano, Daniel; Gurney, Howard; Donskov, Frede; Peltola, Katriina; Wagstaff, John; Gauler, Thomas C; Ueda, Takeshi; Zhao, Huanyu; Waxman, Ian M; Motzer, Robert J.
Afiliação
  • Escudier B; Gustave Roussy, Villejuif, France. Electronic address: escudier@gustaveroussy.fr.
  • Sharma P; MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
  • McDermott DF; Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, MA, USA.
  • George S; Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Hammers HJ; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
  • Srinivas S; Stanford Cancer Institute, Stanford, CA, USA.
  • Tykodi SS; University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Sosman JA; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Procopio G; Fondazione Istituto Nazionale Tumori, Milan, Italy.
  • Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Castellano D; Hospital Universitario 12 De Octubre, Madrid, Spain.
  • Gurney H; Westmead Hospital, Westmead, NSW, Australia.
  • Donskov F; Aarhus University Hospital, Aarhus, Denmark.
  • Peltola K; Comprehensive Cancer Center, Helsinki University Central Hospital Cancer Center, Helsinki, Finland.
  • Wagstaff J; South West Wales Cancer Institute and Swansea University College of Medicine, Swansea, UK.
  • Gauler TC; University Hospital Essen of University of Duisburg-Essen, Essen, Germany.
  • Ueda T; Chiba Cancer Center, Chiba, Japan.
  • Zhao H; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Waxman IM; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Motzer RJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Eur Urol ; 72(6): 962-971, 2017 12.
Article em En | MEDLINE | ID: mdl-28262413
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Everolimo / Antineoplásicos Imunológicos / Neoplasias Renais / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Everolimo / Antineoplásicos Imunológicos / Neoplasias Renais / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Ano de publicação: 2017 Tipo de documento: Article